11 Stanley Druckenmiller Reata Pharmaceuticals Trades
The first Reata Pharmaceuticals trade was made in Q3 2019.
Since then Stanley Druckenmiller bought shares six more times and sold shares on four occasions. The investor completely sold their stake between Q4 2021 and Q1 2023.
Avg closing price
Price range
Sold -59 Thousand shares
Q1 2023
Avg closing price
$58.68
Price range
$30.85
-
$93.17
Sold 85.5% shares (-347 Thousand shares)
Q1 2022
Avg closing price
$29.67
Price range
$24.12
-
$39.60
Sold 41.5% shares (-289 Thousand shares)
Q4 2021
Avg closing price
$77.38
Price range
$25.61
-
$110.96
Increased shares by 9.1% (+57.7 Thousand shares)
Q3 2021
Avg closing price
$117.22
Price range
$100.00
-
$143.02
Sold 15.0% shares (-113 Thousand shares)
Q2 2021
Avg closing price
$112.92
Price range
$78.27
-
$151.29
Increased shares by 37.9% (+206 Thousand shares)
Q4 2020
Avg closing price
$131.41
Price range
$102.03
-
$184.62
Increased shares by 2.1% (+11 Thousand shares)
Q3 2020
Avg closing price
$124.95
Price range
$93.53
-
$163.34
Increased shares by 0.2% (+1 Thousand shares)
Q2 2020
Avg closing price
$152.02
Price range
$126.30
-
$176.56
Increased shares by 24.6% (+105 Thousand shares)
Q1 2020
Avg closing price
$193.06
Price range
$124.16
-
$247.74
Increased shares by 146.3% (+253 Thousand shares)
Q4 2019